Future evaluations would require single cell RNA sequencing, with which we could evaluate the stochastic combinations of somatic inactivation of Bap1, Pbrm1, and Setd2 in individual animals; this approach could provide insights into the step-wise ccRCC tumorigenesis. This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.